MediFind
Condition

Acromicric Dysplasia

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 45
  • Start Date: September 9, 2020
A Multi-Cohort Phase 2 Dose-Escalation Study of ARQ 092 (Miransertib) in Proteus Syndrome
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 600
  • Start Date: October 1, 2018
GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 85
  • Start Date: May 30, 2017
A Phase 1/2 Study of ARQ 092 (Miransertib) in Subjects With PIK3CA-related Overgrowth Spectrum (PROS) and Proteus Syndrome (PS) (MOSAIC)
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 40
  • Start Date: May 11, 2017
Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 1000
  • Start Date: July 2016
Genetic Modifiers of 22q11.2 Deletion Syndrome
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 6
  • Start Date: November 16, 2015
Phase 1 Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 300
  • Start Date: March 2014
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 20000
  • Start Date: July 2010
Coordination of Rare Diseases at Sanford
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 1500
  • Start Date: April 27, 1994
The Phenotype and Etiology of Proteus Syndrome and Related Overgrowth Disorders